Evaluation of the ‘Colli-Pee’, a first-void urine collection device for self-sampling at home for the detection of sexually transmitted infections, versus a routine clinic-based urine collection in a one-to-one comparison study design

You are here

Evaluation of the ‘Colli-Pee’, a first-void urine collection device for self-sampling at home for the detection of sexually transmitted infections, versus a routine clinic-based urine collection in a one-to-one comparison study design: efficacy and acceptability among MSM in Belgium

De Baetselier et al, BMJ Open 2019 (Publication)

Aim: To compare the STI test results obtained with the urine collected in the clinic, versus self-collected urine with Colli-Pee® at home by Men who have Sex with Men (MSM) in Belgium. Further, evaluation of the user-friendliness and acceptability of the Colli-Pee device.

Partners: Institute of Tropical Medicine Antwerp - HIV/STI Reference Laboratory (Belgium)

Results:  11  additional infections were found in home-based samples collected with Colli-Pee®3 Chlamydia trachomatis (CT), 2 Neisseria gonorrhoeae (NG), 6 Mycoplasma genitalium (MG) infections, compared to the clinic-collected samples. A total of three STIs (1 CT and 2 MG infections) were not  detected  in the home-based  sample. The with Colli-Pee® device was also found to be easy (92%).

https://pubmed.ncbi.nlm.nih.gov/30948618/

 

Additionally, the following posters report the interim results that led to the publication:

Colli-Pee®: A new device to collect first-void urine at home for molecular detection of STIs

De Baetselier et al, World IUSTI San Paolo, 2017 (Poster)

Aim: Evaluate the use of Colli-Pee® collected urine mailed by regular post for sexually transmitted infection (STI) detection among Men who have Sex with Men (MSM) who participated in a Belgian HIV prevention study

Partners: Institute of Tropical Medicine Antwerp - HIV/STI Reference Laboratory (Belgium)

Results: Colli-Pee® is feasible and a convenient way to collect urine at home for STI testing. This may be particularly relevant for populations that need frequent STI testing (e.g. PrEP users) and patients who prefer home-testing.